{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:10:18Z","timestamp":1789517418910,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3485,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.virol.2003.11.015","type":"journal-article","created":{"date-parts":[[2004,2,28]],"date-time":"2004-02-28T05:31:43Z","timestamp":1077946303000},"page":"474-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model"],"prefix":"10.1016","volume":"318","author":[{"given":"R.Mark","family":"Buller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelita","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Schriewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora","family":"Melman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Beadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Y","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2003.11.015_BIB1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0026-895X(25)08630-4","article-title":"Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates","volume":"47","author":"Aduma","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.virol.2003.11.015_BIB2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/mol.63.3.678","article-title":"Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism","volume":"63","author":"Aldern","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.virol.2003.11.015_BIB3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/AAC.46.8.2381-2386.2002","article-title":"Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro","volume":"46","author":"Beadle","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.015_BIB5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2003.11.015_BIB6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(01)00220-0","article-title":"Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir","volume":"54","author":"Bray","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/mr.55.1.80-122.1991","article-title":"Poxvirus pathogenesis","volume":"55","author":"Buller","year":"1991","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.virol.2003.11.015_BIB8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6822(92)90445-U","article-title":"Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene","volume":"187","author":"Chen","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virol.2003.11.015_BIB9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0006-2952(93)90670-R","article-title":"Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells","volume":"46","author":"Connelly","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.virol.2003.11.015_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/00222615-47-1-1","article-title":"Acyclic nucleoside phosphonates: a new dimension to the chemotherapy of DNA virus and retrovirus infections","volume":"47","author":"De Clercq","year":"1998","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.virol.2003.11.015_BIB12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"De Clercq","year":"1987","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB13","series-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.virol.2003.11.015_BIB14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volumes of laboratory animals","volume":"150","author":"Guyton","year":"1947","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.virol.2003.11.015_BIB15","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0006-2952(97)82446-X","article-title":"Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro","volume":"53","author":"Hostetler","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.virol.2003.11.015_BIB24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(02)00198-5","article-title":"In vitro activity of potential anti-poxvirus agents","volume":"57","author":"Kern","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.015_BIB17","first-page":"16.15.1","article-title":"Expression of proteins in mammalian cells using vaccinia viral vectors. Overview of the vaccinia virus expression system","volume":"vol. 3","author":"Moss","year":"1998"},{"key":"10.1016\/j.virol.2003.11.015_BIB18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jmv.1890410312","article-title":"Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice","volume":"41","author":"Neyts","year":"1993","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2003.11.015_BIB19","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/S0021-9258(18)99456-1","article-title":"Incorporation of dietary lecithin and lysolecithin into lymph chylomicrons in the rat","volume":"242","author":"Scow","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2003.11.015_BIB20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0166-3542(00)00105-4","article-title":"Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir","volume":"47","author":"Smee","year":"2000","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0166-3542(01)00159-0","article-title":"Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice","volume":"52","author":"Smee","year":"2001","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0166-3542(95)00829-2","article-title":"Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects","volume":"29","author":"Wachsman","year":"1996","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.015_BIB23","first-page":"41","article-title":"Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL\/6j, BALB\/cByj and AKR\/J inbred mice","volume":"35","author":"Wallace","year":"1985","journal-title":"Lab. Anim. Sci."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682203008456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682203008456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:24:52Z","timestamp":1758583492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682203008456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0042682203008456"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2003.11.015","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2003.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}